NHS strikes another deal with clinical AI company Sensyne HealthSensyne Health has signed a five-year non-exclusive Strategic Research Agreement (SRA) with Milton Keynes University Hospital NHS Foundation Share XNHS strikes another deal with clinical AI company Sensyne Healthhttps://pharmaphorum.com/news/nhs-strikes-another-deal-with-sensyne-health/
Novartis launches digital health hub in CanadaNovartis is opening a new digital health innovation hub in Canada to help develop “scalable, digital solutions” for Share XNovartis launches digital health hub in Canadahttps://pharmaphorum.com/digital/novartis-launches-digital-health-hub-in-canada/
Akili presents new real-world data from therapeutic ADHD video gameAkili has new data from its childhood hyperactivity therapeutic video game EndeavorRx, as the company builds a case Share XAkili presents new real-world data from therapeutic ADHD video gamehttps://pharmaphorum.com/news/akili-presents-new-real-world-data-from-therapeutic-adhd-video-game/
On-skin printing of sensors could monitor COVID-19 symptomsScientists say on-skin printing could be used to create on-body sensors to monitor physiological signals and devices to Share XOn-skin printing of sensors could monitor COVID-19 symptomshttps://pharmaphorum.com/news/on-skin-printing-of-sensors-could-monitor-covid-19-symptoms/
COVID-19 ventilator demand fuels Philips Q3 salesHuge demand for ventilators and patient monitors spurred third quarter sales for Royal Philips, the company announced. The Share XCOVID-19 ventilator demand fuels Philips Q3 saleshttps://pharmaphorum.com/news/covid-19-ventilator-demand-fuels-philips-q3-sales/
UK trials digital ‘health passport’ to help borders reopenRegular fliers are used to long queues to clear security – but a rigorous COVID-19 testing regime could Share XUK trials digital ‘health passport’ to help borders reopenhttps://pharmaphorum.com/news/uk-trials-digital-health-passport-to-help-borders-reopen/
Boehringer, Yale trial digital tech in heart failurePatients with heart failure often have a dismal prognosis as the condition usually worsens over time, but a Share XBoehringer, Yale trial digital tech in heart failurehttps://pharmaphorum.com/news/boehringer-yale-trial-digital-tech-in-heart-failure/
Astellas doubles down on partnership and buys bioelectronics firm iotaAstellas Pharma is to buy bioelectronic medical devices firm iota Biosciences in a deal worth up to $429m, Share XAstellas doubles down on partnership and buys bioelectronics firm iotahttps://pharmaphorum.com/news/astellas-doubles-down-on-partnership-and-buys-bioelectronics-firm-iota/
Blue Oak taps AI specialist Exscientia for CNS drug discoveryUS startup Blue Oak Pharma has joined a lengthening list of companies turning to Exscientia of the UK Share XBlue Oak taps AI specialist Exscientia for CNS drug discoveryhttps://pharmaphorum.com/news/blue-oak-taps-ai-specialist-exscientia-for-cns-drug-discovery/
Online male health clinic hires former NHSX director to guide medical strategyAn online health clinic for men, Numan, has completed a £10m series A funding round to expand business. Share XOnline male health clinic hires former NHSX director to guide medical strategyhttps://pharmaphorum.com/news/online-male-health-clinic-hires-former-nhsx-chief-to-guide-medical-strategy/
Record number of health firms feature in UK top 100 private tech listA record number of health and medtech companies have been included in the Sunday Times Sage Tech Track Share XRecord number of health firms feature in UK top 100 private tech listhttps://pharmaphorum.com/news/babylon-among/
UK’s COVID-19 app has sent one venue alert, despite reports of rising infection ratesIt was supposed to be at the heart of the UK government’s fight against coronavirus – but after Share XUK’s COVID-19 app has sent one venue alert, despite reports of rising infection rateshttps://pharmaphorum.com/news/uks-covid-19-app-has-sent-one-venue-alert-despite-government-plans-to-close-pubs-in-england/
NHS digital triage provider to expand with £5m investmentEquity investor Gresham House has invested £5m into the NHS’s digital triage provider eConsult Health, allowing the service Share XNHS digital triage provider to expand with £5m investmenthttps://pharmaphorum.com/news/nhs-digital-triage-provider-to-expand-with-5m-investment/
RHYTHM AI cleared for large trial of atrial fibrillation mapping toolUK-based RHYTHM AI is to go ahead with a larger clinical trial of its artificial intelligence (AI)-driven system, Share XRHYTHM AI cleared for large trial of atrial fibrillation mapping toolhttps://pharmaphorum.com/news/rhythm-ai-cleared-for-large-trial-of-atrial-fibrillation-mapping-tool/
Toppan and FIGUR8 press on with remote physical training guidance pilotJapan’s Toppan Printing and MIT spin-off FIGUR8 have announced results of a pilot scheme testing a remote physical Share XToppan and FIGUR8 press on with remote physical training guidance pilothttps://pharmaphorum.com/news/toppan-and-figur8-press-on-with-remote-physical-training-guidance-pilot/
Excel spreadsheet blamed for UK’s COVID-19 test and trace woesAn Excel spreadsheet was behind IT glitch that caused thousands of positive COVID-19 tests to be omitted from Share XExcel spreadsheet blamed for UK’s COVID-19 test and trace woeshttps://pharmaphorum.com/news/excel-spreadsheet-blamed-for-uks-covid-19-test-and-trace-woes/
Your.MD secures $30m to expand self-care app HealthilyDigital health firm Your.MD has secured $30 million in a Series A round investment led by the consumer Share XYour.MD secures $30m to expand self-care app Healthilyhttps://pharmaphorum.com/news/your-md-secures-30m-to-expand-self-care-app-healthily/
Orexo eyes opioid use disorder app launch before year-endSweden’s Orexo says its opioid use disorder (OUD) digital therapeutic – now christened Modia – is on course Share XOrexo eyes opioid use disorder app launch before year-endhttps://pharmaphorum.com/news/orexo-eyes-opioid-use-disorder-app-launch-before-year-end/
